A study comparing preprandial vs. postprandial insulin glulisine in patients initiating a basal–bolus regimen for type 2 diabetes showed that nocturnal hypoglycemia rates were higher in the postprandial administration group [19]. This evidence concerns the gene INS and type 2 diabetes mellitus.